Consumer guide · India · Updated 2026
Best Cough Syrup in India (2026): What the New Rules Changed, and How to Choose Correctly
The honest answer to “which is the best cough syrup in India” is no longer a brand name. Since 16 June 2026, syrup formulations have been removed from the Schedule K exemption under the Drugs Rules, 1945, so cough syrups are dispensed against a doctor’s prescription rather than picked off an open shelf.1
Regulatory status
Cough syrups in India are now prescription-only
This is the single fact that makes every older cough syrup comparison article obsolete. It changes what a reader should do next, not just what they should read.
What the amendment did
Drugs (Fifth Amendment) Rules, 2026
The Union Ministry of Health and Family Welfare notified the amendment deleting the word “syrups” from Schedule K of the Drugs Rules, 1945. Schedule K had exempted certain products from parts of the retail sale-licensing framework. With that exemption withdrawn, syrup formulations, including common cough syrups, are supplied through licensed pharmacies against a prescription. Lozenges were not part of this change and remain over the counter.1
The change followed sustained scrutiny of oral liquid formulations. In October 2025 the Central Drugs Standard Control Organisation reported to the World Health Organization the presence of diethylene glycol in oral liquid medicines, and WHO issued a medical product alert naming the affected products after clusters of acute illness and child deaths in India.3
Manufacturers reading this from the other side of the counter can follow the quality-system implications through our comparison of WHO-GMP and USFDA compliance expectations.
Step 1 · Classify
Wet cough or dry cough
Coughing clears the airway, so the goal is to work with the cough rather than against it. The single most useful thing you can tell a doctor is whether the cough brings anything up. Select the pattern that matches.
Productive
A cough that clears something
The cough sounds chesty, feels like it is shifting material, and produces sputum. It commonly accompanies a cold or a lower respiratory infection. The mucus is doing a job, so suppressing the cough is the wrong direction.
For a formulation-level breakdown of this category, see our guide to wet cough syrups in India.
Ingredient class
Expectorants and mucolytics
Intended to make secretions easier to shift. Guaifenesin is the most familiar expectorant in this group. Its regulatory position is worth knowing: in the UK, guaifenesin-containing cough medicines are not for children under 6, and are pharmacy-supervised for ages 6 to 12.4
- Fluids and rest are placed as the first-line approach for cough.25
- Most coughs clear without treatment within about three weeks.5
Non-productive
A cough that produces nothing
The cough is scratchy and repetitive, often worse at night, and nothing comes up. It frequently follows a viral illness or accompanies airway irritation.
Our companion guide covers this category in more depth: dry cough syrups for adults.
Ingredient class
Cough suppressants
These act on the cough reflex. Dextromethorphan is the common one. The evidence base is modest: guideline review found mixed results, with some suggestion of benefit from a single high dose in adults and other evidence of no effect, alongside a possible increase in adverse effects.4
Dextromethorphan is not banned in India. What has been restricted is a set of fixed-dose combinations containing it, chiefly those combined with antihistamines and decongestants, barred in children below 4 years.11 It is also misused recreationally at doses far above therapeutic levels, which is not a small consideration.
Needs assessment
If you cannot tell, do not guess
A cough that changes character, a cough with wheeze, a cough with fever that is not settling, or a cough in someone with asthma or a lung condition needs a clinical assessment rather than a category label. Since a prescription is required in any case, the assessment is the necessary step, not an optional one.1
One general point from national advisory guidance: combinations of multiple active ingredients should be avoided where a single agent will do, because they add exposure without adding benefit.2
Step 2 · Eligibility
Age and pregnancy checker
Age is the most restrictive variable in Indian cough syrup rules, and the restrictions tightened sharply after October 2025. Select an age band to see the position that currently applies. This tool reports rules and advisory positions. It gives no doses, and it is not a substitute for a prescription.
Not appropriate
Infant under 1 year
Cough and cold medications should not be prescribed or dispensed to children under 2 years, per the advisory issued by the Directorate General of Health Services to all States and Union Territories. Honey is also unsuitable below 12 months because of botulism risk. Any cough in an infant needs medical assessment rather than a home remedy.
Sources: 2, 10
Parents comparing paediatric formulations should read our dedicated guide to cough syrups for children in India alongside the restrictions above.
Reference
The age rules at a glance
Indian positions first, then published UK ingredient-level positions. UK rules are not Indian law; they are included because they are dated, specific and useful for understanding an ingredient’s safety profile.
| Rule or advisory | Age restriction | Issued by | Ref |
|---|---|---|---|
| Cough and cold medications not to be prescribed or dispensed | Under 2 years | DGHS, MoHFW India, Oct 2025 | 2 |
| Generally not recommended | Under 5 years | DGHS, MoHFW India, Oct 2025 | 2 |
| FDC of chlorpheniramine maleate with phenylephrine hydrochloride restricted | Under 4 years | CDSCO, India | 8 |
| Certain dextromethorphan fixed-dose combinations restricted | Under 4 years | CDSCO, India | 11 |
| Over-the-counter cough and cold remedies, including decongestants | Not under 6 years | NHS, United Kingdom | 6 |
| Guaifenesin and ipecacuanha cough medicines | Not under 6 years; pharmacy-supervised 6 to 12 | MHRA, cited in NICE NG120 | 4 |
| Dextromethorphan, over-the-counter products | Not under 12 years | MHRA, cited in NICE NG120 | 4 |
| Codeine-containing cough medicines | Not under 12 years; not advised under 18 with breathing problems | MHRA, cited in NICE NG120 | 4 |
| Honey | Not under 12 months | NHS; Mayo Clinic | 5, 10 |
Step 3 · Understand the label
What the ingredient classes actually do
Cough syrup labels list several actives with unfamiliar names. Understanding the class is more useful than memorising brands, particularly now that the specific product comes from a prescriber.
Intended to make secretions easier to clear in a productive cough. Guaifenesin is the widely used expectorant; mucolytic agents such as ambroxol, bromhexine and carbocisteine are also used in Indian formulations.
Limits to know: guaifenesin-containing cough medicines are restricted below 6 years in the UK and pharmacy-supervised for ages 6 to 12.4 Guideline review of over-the-counter cough medicines as a group found the evidence for symptom benefit weak.4
Intended to reduce the cough reflex in a dry, non-productive cough. Dextromethorphan is the main agent in this class in India; codeine and pholcodine appear in this class internationally.
Limits to know: the evidence for dextromethorphan is mixed, with a possible increase in adverse effects, mainly gastrointestinal upset and dizziness, and codeine was assessed as having no benefit on cough symptoms.4 In India, several dextromethorphan fixed-dose combinations are restricted below 4 years.11 Dextromethorphan also carries a recognised misuse risk at high doses.
Added where an allergic component or post-nasal drip contributes to the cough. Older sedating antihistamines such as chlorpheniramine cause drowsiness, which matters for driving, machinery operation and daytime work.
Limits to know: the fixed-dose combination of chlorpheniramine maleate with phenylephrine hydrochloride is restricted for use in children below 4 years in India, with a warning statement required on the label and package insert.8
Added where nasal congestion accompanies the cough. Phenylephrine is the common one in Indian combination syrups.
Limits to know: UK guidance advises against over-the-counter cough and cold remedies including decongestants in children under 6 unless a doctor or pharmacist has advised it.6 Decongestants can be unsuitable where blood pressure or cardiac conditions are present, which is a matter for the prescriber.
Beta-2 agonists such as salbutamol and levosalbutamol are sometimes combined with an expectorant where airway narrowing accompanies a productive cough.
Limits to know: airway narrowing is a clinical finding, not something a patient should self-identify from a label. National advisory guidance also asks that multiple drug combinations be avoided in children.2 These formulations belong firmly within a prescribed treatment plan.
A homemade remedy of honey and lemon is described by NHS guidance as likely to be as useful as a cough medicine and safer to take, with the qualification that evidence is limited.57 Honey has been studied against dextromethorphan in children, with honey scoring at least as well in the reported trials, though higher-quality studies are still needed.910
Absolute limit: honey must not be given below 12 months of age because of botulism risk.710 Do not give hot drinks to small children.5
For a worked example of a herbal formulation, see our review of an ayurvedic cough syrup. Herbal preparations can still interact with prescription medicines, so tell your doctor about anything you are already taking.
Evidence
The part most cough syrup pages leave out
Efficacy
The evidence for cough medicines is weak
NHS guidance states plainly that there is no evidence that cough medicines work.7 Guideline review of the over-the-counter class found mixed and low-quality evidence across agents, including for the two most familiar ones.4
That does not make syrups useless in every case. It does mean the expected gain is symptom comfort of uncertain size, which is why exposure, age restrictions and product quality carry proportionally more weight in the decision.
Natural course
Most coughs resolve on their own
Most coughs clear without treatment within about three weeks.5 Indian advisory guidance makes the same point for children, describing most acute cough illnesses as self-limiting and often resolving without medication, with hydration, rest and supportive measures as the first-line approach.2
The useful reframing: the question is not which syrup is strongest, but whether a syrup adds enough to justify the exposure for this person at this age.
Step 4 · Verify
Pack safety checks before the first dose
The child deaths investigated in 2025 were contamination events, not dosing errors. Diethylene glycol and ethylene glycol are industrial solvents with no place in a medicine, and WHO issued a medical product alert naming specific affected batches after CDSCO reported detections.3 No consumer can test for a contaminant at home. What a consumer can do is check the supply chain and the label. Nothing below is stored or sent; the list resets when you reload the page.
Verification progress
0 of 6 checks cleared
If a batch is recalled: stop use and return it to the pharmacy. Adverse reactions can be reported through the Pharmacovigilance Programme of India. A contamination event is a manufacturing quality failure, and no amount of careful shopping protects against a solvent substitution upstream. Buying through licensed channels is what narrows the exposure.
Escalate
When a cough is not a cough syrup problem
Seek medical review promptly
Any one of these overrides the rest of this page
- Difficulty breathing, rapid breathing, or breathlessness at rest.
- Blood in the sputum.
- Chest pain with the cough.
- Cough persisting beyond three weeks.5
- Unexplained weight loss, night sweats or persistent fever, which in India also raise the question of tuberculosis.
- A child who is drowsy, feeding poorly, passing less urine, or deteriorating rather than improving.
- Rash, facial or throat swelling, or breathing difficulty after a dose, which suggests an allergic reaction. Stop the medicine and seek care.
Emergency: a child under 6 who is unable to swallow fluids or saliva, or who has difficulty breathing, needs emergency care rather than a pharmacy visit.6
Related guides
Category-level comparisons on Laafon
These guides go deeper into individual formulation categories. Read them alongside the prescription requirement and the age restrictions on this page, which apply to every product they discuss.
FAQs
Questions readers ask about cough syrup in India
Regulatory or formulation question about oral liquids?
Laafon Galaxy Pharmaceuticals advises on pharmaceutical quality, regulatory affairs and manufacturing compliance. For clinical advice about your own cough, please consult a registered medical practitioner. You can also visit our contact page.
References
- India ends over-the-counter sale of cough syrups without prescription: what new rules say. ThePrint; 2026. Reporting the Drugs (Fifth Amendment) Rules, 2026, Ministry of Health and Family Welfare, removing “syrups” from Schedule K of the Drugs Rules, 1945. Available from: theprint.in
- Ministry of Health and Family Welfare, Government of India. Union Health Secretary chairs high-level meeting with States and UTs on quality and rational use of cough syrups, referencing the DGHS advisory on rational use of cough syrups in paediatric populations. Press Information Bureau; 2025. Available from: pib.gov.in
- World Health Organization. Medical Product Alert No. 5/2025: substandard (contaminated) oral liquid medicines. Geneva: WHO; 2025. Available from: who.int
- National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing. NICE guideline NG120, summary of the evidence. London: NICE; 2019. Available from: nice.org.uk
- National Health Service. Cough. NHS; 2024. Available from: nhs.uk
- National Health Service. Colds, coughs and ear infections in children. NHS; 2024. Available from: nhs.uk
- NHS inform, NHS Scotland. Cough. 2026. Available from: nhsinform.scot
- India’s drug regulator bans anti-cold syrup for under-4 children. The Tribune; 2023. Reporting the CDSCO restriction on the fixed-dose combination of chlorpheniramine maleate IP 2 mg with phenylephrine hydrochloride IP 5 mg. Available from: tribuneindia.com
- Oduwole O, Udoh EE, Oyo-Ita A, Meremikwu MM. Honey for acute cough in children. Cochrane Database of Systematic Reviews. 2018. doi:10.1002/14651858.CD007094.pub5
- Mayo Clinic. Honey: an effective cough remedy? Rochester: Mayo Foundation for Medical Education and Research; 2024. Available from: mayoclinic.org
- Government dismisses rumours of ban on dextromethorphan cough syrups. Press Information Bureau Fact Check Unit, reported by News on AIR; 2025. Available from: newsonair.gov.in
This page is educational and is not a diagnosis, a prescription, or a substitute for clinical assessment. It recommends no brand and states no doses; doses come from your prescriber and the approved product label. Regulatory positions change, and the rules summarised here reflect the sources listed above at the time of writing. Verify current status with a registered medical practitioner or pharmacist before acting. Reviewed by Dr. Yogesh Chaudhary.
